Unknown OBSERVATIONAL NCT02647164

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

Sponsor: GenoSaber

Conditions Non-small-cell Lung Carcinoma

Updated 8 times since 2017 Last updated: Jan 5, 2016 Started: Jan 31, 2016 Primary completion: Sep 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Non-small-cell Lung Carcinoma and is currently ongoing. GenoSaber leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Oct 2018 — Jan 2021 [monthly]

Unknown Status

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Oct 2018 [monthly]

Not Yet Recruiting

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Not Yet Recruiting

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Not Yet Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GenoSaber

Data source: GenoSaber

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.